Abstract:Background: Proteinuria has been associated with transplant loss and mortality in kidney transplant recipients. Both spot samples (albumin-creatinine ratio [ACR] and protein-creatinine ratio [PCR]) and 24-hour collections (albumin excretion rate [AER] and protein excretion rate [PER]) have been used to quantify protein excretion, but which measurement is a better predictor of outcomes in kidney transplantation remains uncertain. Study design: Observational cohort study. Setting & participants: Tertiary care center, 207 kidney transplant recipients who were enrolled in a prospective study to measure glomerular filtration rate. Consecutive patients who met inclusion criteria were approached. Predictors: ACR and PCR in spot urine samples, AER and PER in 24-hour urine collections. Outcomes: Primary outcome included transplant loss, doubling of serum creatinine level, or death. Measurements: Urine and serum creatinine were measured using a modified Jaffé reaction that had not been standardized by isotope-dilution mass spectrometry. Urine albumin was measured by immunoturbidimetry. Urine protein was measured by pyrogallol red molybdate complex formation using a timed end point method. Results: Mean follow-up was 6.4 years and 22% developed the primary end point. Multivariable-adjusted areas under the receiver operating characteristic curves were similar for the different protein measurements: ACR (0.85; 95% CI, 0.79-0.89), PCR (0.84; 95% CI, 0.79-0.89), PER (0.86; 95% CI, 0.80-0.90), and AER (0.83; 95% CI, 0.78-0.88). C Index values also were similar for the different proteinuria measurements: 0.87 (95% CI, 0.79-0.95), 0.86 (95% CI, 0.79-0.94), 0.88 (95% CI, 0.82-0.94), and 0.86 (95% CI, 0.77-0.95) for log(ACR), log(PCR), log(PER), and log(AER), respectively. Limitations: Single-center study. Measurement of proteinuria was at variable times posttransplantation. Conclusions: Spot and 24-hour measurements of albumin and protein excretion are similar predictors of doubling of serum creatinine level, transplant loss, and death. Thus, spot urine samples are a suitable alternative to 24-hour urine collection for measuring protein excretion in this population.

Microproteinuria for Detecting Calcineurin Inhibitor-Related Nephrotoxicity after Liver Transplantation

Non-invasive detection of acute renal allograft rejection by measurement of vascular endothelial growth factor in urine.

Prediction of Subclinical Renal Allograft Rejection by Vascular Endothelial Growth Factor in Serum and Urine.

Effect Of Earlier-Proteinuria On Graft Functions After One-Year Living Donor Renal Transplantation

Clinical Analysis of 2520 Renal Transplantations in One Center

Urinary C-X-C Motif Chemokines 13 is a Noninvasive Biomarker of Antibody-Mediated Renal Allograft Rejection

Pretransplant Renal Function Evaluated by Serum Cystatin C Was Associated with Mortality after Liver Transplantation: a Single-Center Experience

Conversion from Calcineurin Inhibitors to Sirolimus in Chronic Allograft Nephropathy: a 4-Year Prospective Study

Urinary neutrophil gelatinase-associated lipocalin: A potential biomarker for predicting rapid progression of drug-induced chronic tubulointerstitial nephritis.

Long-term Effectiveness of Anti-Interleukin-2 Receptor Antibodies Vs.rabbit Antithymocyte Globulin As Induction Therapy in Kidney Transplantation

Long term follow up of renal transplant recipients with borderline change

Acute Renal Allograft Rejection is Associated with Increased Levels of Vascular Endothelial Growth Factor in the Urine

Application of immune cell functional assay in monitoring immune status in renal transplant recipients

Predicting kidney transplantation outcomes using proteinuria ascertained from spot urine samples versus timed urine collections

A randomized controlled trial to evaluate efficacy and safety of early conversion to a low-dose calcineurin inhibitor combined with sirolimus in renal transplant patients

The Prevalence Of Immunologic Injury In Renal Allograft Recipients With De Novo Proteinuria

A multi-center randomized controlled trial to evaluate efficacy and safety of early conversion to a low-dose calcineurin inhibitor combined with sirolimus in renal transplant patients

A quantitative assessment of renal function utilizing albuminuria in pediatric heart transplant recipients

DOPAMINE-1 RECEPTOR SUBTYPE (D1A AND D1B) EXPRESSION IN MICRODISSECTED RAT NEPHRON SEGMENTS. • 1703

Evaluation of gene panel mRNAs in urine samples of kidney transplant recipients as a non-invasive tool of graft function

Prolymphocytic leukemia treated with natural and recombinant alpha-interferon.